Clinical trial
Adjuvant Chemotherapy Compared With Observation in Treating Patients With…
NCT00002477 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00002477 |
|---|---|
| Title | Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer |
| Official title | Phase III Randomized Study of Adjuvant Therapy With a Platinum-Containing Regimen (e.g., CBDCA or CAP: CTX/DOX/CDDP) vs No Adjuvant Therapy in Patients With Fully Resected Early Stage Ovarian Cancer |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, cyclophosphamide, doxorubicin hydrochloride |
| Start date | Apr 1, 1991 |
| First posted | May 26, 2004 |
| Last update posted | Dec 18, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: